Donders, G., Neven, P., Moegele, M., Lintermans, A., Bellen, G., Prasauskas, V., . . . Buchholz, S. (2014). Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: Pharmacokinetic, safety, and efficacy phase I clinical study. Springer US.

Donders, Gilbert, Patrick Neven, Maximilian Moegele, Anneleen Lintermans, Gert Bellen, Valdas Prasauskas, Philipp Grob, Olaf Ortmann, and Stefan Buchholz. Ultra-low-dose Estriol and Lactobacillus Acidophilus Vaginal Tablets (Gynoflor®) for Vaginal Atrophy in Postmenopausal Breast Cancer Patients On Aromatase Inhibitors: Pharmacokinetic, Safety, and Efficacy Phase I Clinical Study. Springer US, 2014.

Donders, Gilbert, et al. Ultra-low-dose Estriol and Lactobacillus Acidophilus Vaginal Tablets (Gynoflor®) for Vaginal Atrophy in Postmenopausal Breast Cancer Patients On Aromatase Inhibitors: Pharmacokinetic, Safety, and Efficacy Phase I Clinical Study. Springer US, 2014.